The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
December 10th 2025
Many US patients with diabetes cannot afford their medical care. The authors review the impact of interventions that reduced and/or eliminated diabetes-related costs.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
1 Credit / Cardiology, Neurology
View More
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
A Michigan Program Asks the Working Poor to Volunteer to Get Free Dental Care
August 3rd 2017More than 100 million adults don't have dental coverage, which is not an essential health benefit even though data show rising numbers of emergency department cases related to dental problems. A Michigan experiment shows a possible solution, but even the study's author said it is not a panacea.
Read More
Leveraging EHRs for Patient Engagement: Perspectives on Tailored Program Outreach
July 31st 2017Divergent reactions among women at high risk for diabetes highlight challenges of implementing tailored outreach messages, driven by electronic health records, to promote patient engagement in preventive lifestyle programs.
Read More
Study Finds Low Diabetes Risk Among Moderate Drinkers, but What Does It Mean?
July 31st 2017While the study found an association between moderate drinking and a low risk of diabetes, it doesn't prove that a few drinks throughout the week reduces one's risk, according to the UK's National Health Service.
Read More
This Week in Managed Care: July 28, 2017
July 28th 2017This week, the top managed care stories included the Senate rejecting multiple measures to repeal and replace the Affordable Care Act; calls for new payment models in behavioral healthcare; and 2 studies on empowering consumers to find the best prices for medications.
Watch
Dr Alan Carter on Biosimilars in the Insulin Market
July 27th 2017Alan Carter, PharmD, principal investigator and senior advisor at MRIGlobal, and adjunct faculty at University of Missouri—Kansas City School of Pharmacy discusses the influence of biosimilars and follow-ons in the insulin market and their reliability should be validated.
Watch
Gallup-Sharecare Survey Finds 11.6% of US Adults Have Diabetes; Tops CDC Study
July 25th 2017While Gallup-Sharecare and CDC had different ways of calculating diabetes prevalence, the bottom line is the same: the rate is too high and continues to climb in an alarming way. The survey featured breakdowns on diabetes prevalence by occupation.
Read More
Study Finds ACOs Have No Meaningful Impact on Medication Use or Adherence
July 25th 2017Many accountable care organizations participating in the Medicare Shared Savings Program focus on disease control and medication use, but a new study published in JAMA Cardiology has found that the programs have not made any meaningful changes in medication use or adherence.
Read More
"Beyond A1C" Pinpoints Metrics That Matter to Patients for Future FDA Approvals
July 21st 2017Luminaries from the worlds of research, regulation, and advocacy in diabetes gathered in Bethesda, Maryland, to discuss what future rules for drug and device approvals might look like if things like hypoglycemia and time in range had consideration.
Read More
Big Breakfast Key to Lower Weight, Study Finds
July 20th 2017The study found that no matter their eating pattern, participants tended to add weight gradually until age 60, then lose it gradually. But those who had most of their calories earlier in the day gained less and lost weight more rapidly after age 60.
Read More
Dr Andrew Rhinehart: Improving Intermediate Outcomes in Diabetes Research
July 20th 2017Andrew Rhinehart, MD, chief medical officer at Glytec, discusses the transition from intermediate outcomes in diabetes research of glycemic results to harder outcomes that will benefit the patient financially and through their care.
Watch
Just an Hour of Social Time a Week Makes a Difference in Dementia
July 17th 2017The British study found that just an hour a week of added social interaction, and letting patients have a say in their care plan, reduced agitation and improved quality of life for Alzheimer's patients. This method also reduced costs, which has implications for Medicare as the Alzheimer's populaton is expected to grow in Medicare.
Read More